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A B S T R A C T
Brucellosis is a common and multisystemic zoonotic infectious disease. Central nervous system
involvement is rarely seen in brucellosis, with an incidence of 0.5–25%. The aim of this report is to
underline the importance of brucellosis, which is an endemic infection in our country, during the
diagnostic evaluation of stroke.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Brucellosis is a common infectious disease. Humans can
become infected by direct contact with an infected animal, the
consumption of dairy products, and/or inhalation of infectious
particles. It is a systemic zoonotic disease that can persist for years
if not treated, and can cause various complications depending on
the organs affected.1,2 Although it has been completely eradicated
in industrialized countries, brucellosis is an important public
health problem in developing countries such as Turkey.3
A rare but important complication of Brucella infection is
neurobrucellosis, which can be seen at all stages of the disease.
Neurobrucellosis can present with acute or chronic meningoence-
phalitis, myelitis, radiculitis, cranial nerve involvement, brain
abscess, subarachnoid bleeding, and neuropsychiatric symp-
toms.3–5
Central nervous system (CNS) involvement is either due to the
direct effect of the bacterium via cytokines or endotoxins on
peripheral nerves, spinal cord, meninges, and brain or vascular
involvement. Transient cerebral ischemic attacks can be seen
secondary to the vascular–perivascular inﬂammatory reaction or
vascular spasm. Large vessel involvement is rare in neurobrucel-
losis.2,6,7 In this report, we present a case of stroke due to
neurobrucellosis. Our aim is to underline the importance of
neurobrucellosis in the differential diagnosis of stroke in areas
where brucellosis is endemic, such as our country.* Corresponding author.
E-mail address: saimeay@yahoo.com (S. Ay).
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A 28-year-old male patient was hospitalized in the Physical
Medicine and Rehabilitation Department, with a diagnosis of
stroke for rehabilitation. The patient had ﬁrst presented to a
different university hospital with symptoms of sudden speech
disorder, blurred consciousness, andweakness of the left half of the
body.Magnetic resonance imaging (MRI) and cerebral angiography
testing performed at that hospital had revealed a frontoparieto-
temporal infarct in the right cortical area supplied by the middle
cerebral artery (MCA) and a prominent stenotic segment distal to
the right MCA. A stent was placed into the right middle cerebral
artery. Although the patient regained consciousness after this
treatment, he was referred to our clinics for rehabilitation, as his
left hemiparesis had persisted.
During evaluation of the patient at our clinics, we learned that
the patient consumed unpasteurized milk. The patient’s medical
history revealed that he had also presented to a health center with
symptoms such as depressive mood and fatigue, and had been
diagnosed with depression and given medical treatment for this
disorder. However, no resolution of the depression was observed
following this treatment. His family history did not include any
signiﬁcant characteristics. A physical examination was performed
and his vital ﬁndings were recorded: blood pressure 130/80
mmHg, heart rate 78/min, body temperature 37.2 8C. The patient
was still in a markedly depressive mood. Physical examination of
other systems, including the musculoskeletal system, revealed no
abnormal ﬁndings. Neurological examination of the patient
showed that he was conscious, oriented, and cooperative.
However, his speech was dysarthric. He had left facial paralysis,ses. Published by Elsevier Ltd. All rights reserved.
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tendon reﬂexes were brisk. He had pathological reﬂexes and
Achilles clonus. There was spasticity of the left lower extremity,
which wasmore prominent in the gastrocnemius–soleus complex.
He had a good sitting balance and could stand up with support. His
total functional independence measure (FIM) was recorded as 85.
The FIMmeasures independent performance in self-care, sphincter
control, transfers, locomotion, communication, and social cogni-
tion. The possible total score ranges from 18 (lowest level of
independence) to 126 (highest level).
As the patient was young, the etiology of stroke was evaluated
in detail by laboratory testing. Routine blood count, biochemistry,
erythrocyte sedimentation rate, vitamin B12 and folic acid levels,
urinary tests, coagulation proﬁle, hematological tests for hyper-
coagulability, and immunologic markers were within the normal
ranges. C-reactive protein was 26.2 mg/l. Duplex ultrasound of the
carotid arteries, cranial computerized tomography (CT), chest
radiography, and echocardiography were all normal. The Brucella
standard tube agglutination test (Wright test) was negative. As the
blood culture result was positive for Brucella melitensis, a lumbar
puncture was performed. Cerebrospinal ﬂuid (CSF) albumin was
increased at 43 mg/dl, CSF IgG increased at 15 mg/dl, and
oligoclonal IgG was seen on CSF immune ﬁxation electrophoresis.
CSF glucose was decreased at 26 mg/dl and CSF total protein was
increased at 76.8 mg/dl. PCR for Mycobacterium tuberculosis and
CSF cultures for other bacteria were negative. A CSF culture was
positive for Brucella melitensis. As Brucella was positive in both
blood and CSF cultures, the patient was diagnosed with
neurobrucellosis. Cranial MRI showed that there were hemor-
rhagic infarcts in the frontoparietal cortical–subcortical areas
supplied by the right MCA (Figure 1). Angiography was normal. As
well as continuing with his routine rehabilitation program, the
patient also received triple antibiotic treatment consisting of
trimethoprim–sulfamethoxazole 160/800 mg three times a day,
rifampin 900 mg/day, and doxycycline 200 mg/day. CSF analysis
was repeated in the sixth month of therapy. There was no
abnormality on CSF examination. After a year of follow-up,
signiﬁcant improvements in the paresis of the left lower and
upper extremities were recorded. There was no signiﬁcant change
in the level of spasticity. The patient was mobilized with oneFigure 1. Magnetic resonance image of the brain: focal brain involvement of
brucellosis.walking stick. His FIM score increased to 109. The most signiﬁcant
improvement was observed in the depressive mood of the patient
seen during the ﬁrst evaluation.
3. Discussion
Brucellosis is a zoonotic infectious disease with a lowmortality
and high morbidity. It is endemic, especially in the east and
southeast regions of our country, and it can be seen with different
clinical presentations and a variety of complications.8 Neurobru-
cellosis can mimic many central and peripheral nervous diseases,
including transient ischemic and hemorrhagic stroke. CNS
involvement, which has an incidence of 0.5–25%, can be the only
ﬁnding, and clinical ﬁndings can emerge during the late phases of
the disease.9 The clinical presentation of neurological involvement
can be diverse, including meningitis, meningoencephalitis, radi-
culitis, cranial nerve involvement, meningomyelitis, sensorial and
motor abnormalities, cerebellar ataxia, brain or spinal abscess,
stroke, intracranial hypertension, polyradiculoneuritis, transverse
myelitis, and subarachnoid bleeding. Neurological ﬁndings can
present during the active phase of the disease or can emerge
later.2,9,10
Neurological complications such as depression, amnesia, mood
changes, agitation, manic or paranoid behaviors can be seen in
these patients.11 In countries where brucellosis is endemic, such as
Turkey, neurobrucellosis must be kept in mind in the differential
diagnosis of patients with neurological deﬁcits and neuropsychia-
tric symptoms, and these patients should be evaluated for
neurobrucellosis in order to make an early diagnosis and
treatment. The diagnosis of neurobrucellosis is based on CSF
ﬁndings, such as normal or low glucose levels, increase in
lymphocyte count and protein levels, and positivity of Brucella
antibody titer. Bacteria can be isolated in half of the CSF cultures,
thus, culture negativity is not essential for elimination of
neurobrucellosis. Moreover, CSF antibodymay also not be positive.
Furthermore, the blood agglutination test and blood cultures may
also be negative.7,10,12 This case presented for medical care with
stroke and ﬁndings of depression. The patient was young and he
did not have any risk factors for stroke. He had a normal complete
blood count and biochemistry tests. Although the blood Brucella
agglutination test was negative, the bacterium was isolated from
blood culture. Moreover, CSF ﬁndings were in accordance with
neurobrucellosis. As CSF culture was positive for brucellosis, the
ﬁnal diagnosis of neurobrucellosis was made. The CSF ﬁndings are
similar to tuberculous meningitis and can be misleading in the
diagnosis, especially in regions where tuberculosis is common.
Thus, we evaluated our patient for tuberculosis; however there
were no ﬁndings suggesting tuberculosis.
The pathogenesis of ischemic stroke in Brucella infection is not
clear. Preclinical research with Brucella endotoxin on laboratory
animals has shown that vascular and perivascular inﬂammatory
reactions can develop in the endothelial wall. Encephalopathy in
brucellosis is nearly always seen secondary to vascular involve-
ment. Moreover, autoantibodies and immune complex production,
which causes neural involvement, has been reported.2,7,13
Stroke can develop secondary to mycotic aneurysm rupture in
neurobrucellosis. A case who developed neurobrucellosis second-
ary to subarachnoid bleeding due to a basilar artery mycotic
aneurysm rupture has been reported.6
Although the imaging methods are important for the diagnosis
of neurobrucellosis, the test results must be in accordancewith the
patient’s clinical condition in order to have diagnostic value. A focal
cortical cerebral lesion with nodular enhancement and surround-
ing edema, increase in perivascular vascularization and general-
ized inﬂammation of the white matter can be seen on CT and
MRI.9,14 The MRI of our patient showed hemorrhagic infarct areas
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is not speciﬁc for neurobrucellosis, it explains the stroke in our
patient.
In order to prevent complications and relapse in brucellosis,
appropriate combination treatment for a sufﬁcient period of time
is necessary. Doxycycline, streptomycin, rifampin, and trimetho-
prim–sulfamethoxazole are recommended for its treatment. As
the bacterium is located intracellularly, a double or triple
combination regimen is especially important. Furthermore,
combinations including third-generation cephalosporins, ampi-
cillin, imipenem, or ﬂuoroquinolone have also been investigated.
The duration of treatment for neurobrucellosis is 6 months,
however, this duration may be changed based on clinical and
laboratory ﬁndings.15,16 This case also received a combination
treatment. Motor, sensory, or mental alterations are rarely
persistent in patients after treatment and these sequelae,
particularly neuropsychiatric symptoms, generally regress. In
accordance, we also observed signiﬁcant improvement in the
neuropsychiatric symptoms of our patient.
Stroke can be related to many different etiologies, and
neurobrucellosis must be kept in mind especially in young
patients. Although CNS involvement in Brucella infection is rare,
it is more common in regions such as Turkey, where brucellosis is
endemic. A delay in diagnosis can signiﬁcantly increase mortality
and morbidity. In some cases, the disease can cause neuropsy-
chiatric symptoms such as depression, mood changes, delirium,
and hallucination, without signiﬁcant neurological deﬁcits. As
neurobrucellosis can clinically present with such symptoms,
patients must be evaluated with caution. In conclusion, as our
country is one of the regionswhere brucellosis is common, Brucella
and its complications must be kept in mind in the differential
diagnosis of neuropsychiatric symptoms and ﬁndings.
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